FBInvestor
Stocks / Global Blood Therapeutics In
Institutional Ownership

Global Blood Therapeutics In

CUSIP 37890U108COMGBTUSDQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.